两步评分联合可选肾病病理预测脑死亡供肾不良结局
在Eurotransplant框架下开发并验证灵活的2-Step Scores,用于预测脑死亡供肾移植后延迟性移植物功能(DGF)和1年死亡删失移植失败(1y-tl)。训练集DGF n=620、1y-tl n=711,验证集分别为n=158和n=162。Step 1仅用临床预测因子,Step 2对中间风险百分位加入肾病病理更新风险;DGF的c-statistic训练/验证为0.672/0.704,1y-tl为0.700/0.769,加入病理后部分改善,校准训练集良好、验证集中等。
要点
- Step 1仅用临床变量预测DGF和1y-tl,验证集区分度分别为0.704和0.769。
- 对中间风险百分位加入肾病病理可小幅提升预测准确度。
- 评分在验证集区分度不劣于已有评分,但校准仅中等。
核心结论
- 2-Step Scores灵活可选肾病病理,在Eurotransplant临床实践中可能优于已有评分。
研究设计与样本
- 开发与验证研究:DGF训练集n=620、验证集n=158;1y-tl训练集n=711、验证集n=162。
- Step 1用逐步 logistic 回归仅纳入临床预测因子,Step 2对统计相关的中间风险百分位用肾病病理更新风险估计。
主要发现
- Step 1显示DGF风险随冷缺血时间、供受体体质指数、透析龄、HLA-DR错配数或受体巨细胞病毒IgG阳性增加。
- DGF预测在训练集和验证集的c-statistic分别为0.672和0.704。
- 在18%至36%风险区间,加入肾小球数量和Banff cv后DGF预测准确度改善,总体c-statistic分别为0.696和0.701。
- 1y-tl风险随冷缺血时间、HLA-A、-B、-DR错配总和及供者年龄增加,训练集和验证集c-statistic分别为0.700和0.769。
- 加入Banff ct后1y-tl预测改善,c-statistic分别为0.706和0.765;校准训练集良好、验证集中等。
关键数值与推荐
- DGF预测在18%至36%风险百分位区间用肾病病理更新风险。
- 1y-tl预测加入Banff ct后c-statistic由0.700/0.769变为0.706/0.765。
临床怎么用
- 可用于Eurotransplant国家脑死亡供肾接受或丢弃决策时预测DGF和1y-tl风险。
- 评分灵活,可选纳入肾病病理,并可适应心脏死亡后捐献和灌注泵使用场景。
局限性
- 肾病病理耗时且常不可获得,为可选步骤。
- 验证集校准仅中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The decision to accept or discard the increasingly rare and marginal brain-dead donor kidneys in Eurotransplant (ET) countries has to be made without solid evidence. Thus, we developed and validated flexible clinicopathological scores called 2-Step Scores for the prognosis of delayed graft function (DGF) and 1-year death-censored transplant loss (1y-tl) reflecting the current practice of six ET countries including Croatia and Belgium. METHODS: The training set was n = 620 for DGF and n = 711 for 1y-tl, with validation sets n = 158 and n = 162, respectively. In Step 1, stepwise logistic regression models including only clinical predictors were used to estimate the risks. In Step 2, risk estimates were updated for statistically relevant intermediate risk percentiles with nephropathology. RESULTS: Step 1 revealed an increased risk of DGF with increased cold ischaemia time (CIT), donor and recipient body mass index, dialysis vintage, number of HLA-DR mismatches or recipient cytomegalovirus immunoglobulin G positivity. On the training and validation set, c-statistics were 0.672 and 0.704, respectively. At a range between 18% and 36%, accuracy of DGF-prognostication improved with nephropathology including number of glomeruli and Banff cv (updated overall c-statistics of 0.696 and 0.701, respectively). Risk of 1y-tl increased in recipients with CIT, sum of HLA-A, -B, -DR mismatches, and donor age. On training and validation sets, c-statistics were 0.700 and 0.769, respectively. Accuracy of 1y-tl prediction improved (c-statistics = 0.706 and 0.765) with Banff ct. Overall, calibration was good on the training, but moderate on the validation set; discrimination was at least as good as established scores when applied to the validation set. CONCLUSION: Our flexible 2-Step Scores with optional inclusion of time-consuming and often unavailable nephropathology should yield good results for clinical practice in ET, and may be superior to established scores. Our scores are adaptable to donation after cardiac death and perfusion pump use.
引用
- Ernst A, Regele H, Chatzikyrkou C, et al. 2-Step Scores with optional nephropathology for the prediction of adverse outcomes for brain-dead donor kidneys in Eurotransplant. Nephrol Dial Transplant. 2024. PMID: 38632055. doi:10.1093/ndt/gfae093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。